A new spectrofluorimetric method for determination of losartan potassium in rabbit plasma and its application to pharmacokinetic study

被引:10
作者
Demirkaya-Miloglu, Fatma [1 ]
Yaman, Mehmet Emrah [1 ]
Kadioglu, Yucel [1 ]
机构
[1] Ataturk Univ, Dept Analyt Chem, Fac Pharm, TR-25240 Erzurum, Turkey
关键词
Losartan potassium; rabbit plasma; spectrofluorimetry; pharmacokinetic; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; ACTIVE METABOLITE; URINE; EXP3174;
D O I
10.1002/bio.2689
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A new spectrofluorimetric method to determine losartan potassium (LP) in rabbit plasma is described. The method was based on measuring the native fluorescence of LP in acidic medium. Optimum excitation and emission wavelengths were found to be 248 nm and 410 nm, respectively, in methanol that was diluted with a sulfurous acid solution LP was extracted from rabbit plasma by methyl-tertiary-butyl-ether in acidic media and then back extracted with NaOH. The calibration curves were linear between 0.025 and 0.5 mu g/mL with a lower limit of detection 0.004 mu g/mL. Precision and accuracy values of the method were calculated as lower than 4.97% and +/- 5.68, respectively and the recovery of LP from rabbit plasma was higher than 91.1%. In addition, stability studies of LP in rabbit plasma were carried out and demonstrated its good stability at-20 degrees C and at room temperature. The developed and validated method was successfully applied for estimating the pharmacokinetic parameters of LP following oral administrations of a single 10mg LP/kg to rabbits and it could be concluded that the method can be applied to clinical trials. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 23 条
[1]   Angiotensin II type 1 receptor blockers [J].
Burnier, M .
CIRCULATION, 2001, 103 (06) :904-912
[2]   Experimental design methodologies to optimise the spectrofluorimetric determination of Losartan and Valsartan in human urine [J].
Cagigal, E ;
González, L ;
Alonso, RM ;
Jiménez, RM .
TALANTA, 2001, 54 (06) :1121-1133
[3]   Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography [J].
Carlucci, G ;
Palumbo, G ;
Mazzeo, P ;
Quaglia, MG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (01) :185-189
[4]   Spectrofluorimetric method for determination of some angiotensin II receptor antagonists [J].
El-Shaboury, Salwa R. ;
Hussein, Samiha A. ;
Mohamed, Niveen A. ;
El-Sutohy, Mohamed M. .
JOURNAL OF PHARMACEUTICAL ANALYSIS, 2012, 2 (01) :12-18
[5]   SIMULTANEOUS DETERMINATION OF A NOVEL ANGIOTENSIN-II RECEPTOR BLOCKING-AGENT, LOSARTAN, AND ITS METABOLITE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FURTEK, CI ;
LO, MW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (02) :295-301
[6]  
Gavrilins M, 2002, PHARM CHEM J, V36, P227
[7]   Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection [J].
González, L ;
López, JA ;
Alonso, RM ;
Jiménez, RM .
JOURNAL OF CHROMATOGRAPHY A, 2002, 949 (1-2) :49-60
[8]   Solubility of Losartan potassium in different pure solvents from (293.15 to 343.15) K [J].
Guo, Kun ;
Yin, Qiuxiang ;
Yang, Yu ;
Zhang, Meijing ;
Wang, Jingkang .
JOURNAL OF CHEMICAL AND ENGINEERING DATA, 2008, 53 (07) :1467-1469
[9]   Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry [J].
Iwasa, T ;
Takano, T ;
Hara, K ;
Kamai, T .
JOURNAL OF CHROMATOGRAPHY B, 1999, 734 (02) :325-330
[10]  
Jalalizadeh H., 2003, IJPT, V3, P21